Who we are
One of the Leading Global Pharmaceutical Companies, EU GMP–certified Egyptian manufacturer providing innovative diversified specialty care treatments in diffirent therapeutic areas, with a strong presence covering Africa and GCC, to deliver cost-effective critical solutions to healthcare practitioners and their patients across the continent.
News &
Updates
Marcyrl Group celebrates the launch of Ruxotop
Collaborating with The Egyptian Drug Authority (EDA) Marcyrl Group launched a new innovative product with several KOLs in dermatology from around Egypt.
The Egyptian Drug Authority appreciates Marcyrl Group
EDA Appreciation Marcyrl Group for their Distinguished contributions towards upgrading the Egyptian Exports of Medical Products during 2023.
The 64th Annual International Congress of The Egyptian Society of Chest Diseases & Tuberculosis 2023
Marcyrl Group contributes significantly to The Egyptian Society of Chest Diseases and Tuberculosis through pharmaceutical products at the 64th Annual International Congress of The Egyptian Society of Chest Diseases & Tuberculosis 2023.
Marcyrl Group Mingle – The Field Force
Marcyrl Group provides support to the field force by merging them with the corporate vibes to enhance their efforts.
Marcyrl Group trains the Employee
Marcyrl Group always provides different training for the employees to improve their talent and skills by sharing experiences, continuing learning, and building relationships.
Marcyrl Group – Cycle Meetings
Marcyrl Group makes sales funnels easier and more professional through knowledge sharing, training, motivation, strategic planning, and goal setting.
Marcyrl at a glance
30
%
CAGR
200
Products
In 325 SKUs
23
Export markets
in the Middle East
and Africa
300
Pipeline
SKUs
48
Therapeutic classes
with a focus on
chronic areas
3
Facilities with EU GMP-certified
lines and cold chain capabilities
2000+ Members in the team
Leader in hormonal and
respiratory products
in Egypt

Transforming Lives through
Innovation and Excellence
Get to know our
products
We strive to enhance the lives of patients by providing them with accessible and affordable healthcare solutions.
Let’s work together
Export Capabilites
Marcyrl Pharmaceutical Industries, an Egyptian pharmaceutical manufacturer, has secured investment from Development Partners International (DPI) and Amethis. They focus on specialty generics, to improve access to critical care drugs across Africa. Marcyrl’s growth includes expanding its product portfolio and addressing the demand for affordable specialty generics in Africa. The investment underscores the significance of the pharmaceutical sector and Marcyrl’s commitment to bridging healthcare gaps in the continent.

Capitalizing on our EU-approved GMP sites, Marcyrl Pharmaceutical Industries is exporting a wide range portfolio of medicines to 23 export markets including GCC, LEVANT, and AFRICA

Our ambitious plan to expand our export business in Africa, CIS, GCC, and LATAM.
Jobs that make the
world a better place
We strive to enhance the lives of patients by
providing them with accessible and affordable
healthcare solutions.




What would you like to
contact us about?
Get in touch
Get in touch
Get in touch
Get in touch